The inoculation of MOG peptides into C57BL/6 mice induces CD4 + and CD8 + T cells, and recent work has shown that adoptive transfer of the latter population, after extensive in vitro stimulation, can cause EAE in naïve recipient mice. Herein, we have evaluated the incidence and severity of EAE, and the induction of CD4 + and CD8 + T cells, following MOG peptide inoculation of wt mice and of LMP-2KO mice that lack an intact immunoproteasome, a cytoplasmic organelle that is induced by chronic inflammation and that may be important for the presentation of MHC class I epitopes to CD8 + T cells. We report that EAE, evaluated by both clinical and histological criteria, is similar in LMP-2KO mice and wildtype C57B/6 mice (wt) in response to immunization with MOG peptides MOG 35-55 and MOG [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54] , suggesting that the immunoproteasome does not play a key role in the development of demyelinating disease. Furthermore, and consistent with previous reports, peptide-specific CD8 + T cells were barely detectable in the CNS of peptide-immunized mice, although peptide-specific CD4 + T cells were abundant. Therefore, we used a new technique to look for autoreactive CD8 + T cells in MOG peptide-immunized mice, and we report the identification of CD4 + and CD8 + T cells that, as late as 19 days after peptide injection, are actively producing IFNγ in vivo, in response to in vivo antigen contact.
Introduction
Multiple sclerosis (MS) is the most common chronic demyelinating disease of the central nervous system (CNS). CNS infiltration by lymphocytes and macrophages is observed in association with MS lesions, and autoreactive T cells have been implicated as major mediators of pathology. The precise etiology of MS remains unclear, but the study of T cell-mediated myelin injury has yielded important advances in the understanding of MS pathogenesis and in treatment strategies (Steinman and Zamvil, 2006) . Genetic susceptibility plays a part: consistent with its proposed T cell-mediated pathogenesis, MS has been linked with the receptors for IL2 and IL7 (The International Multiple Sclerosis Genetics Consortium, 2007); and also with various MHC class II alleles (Yaouanq et al., 1997; Lincoln et al., 2005; Yeo et al., 2007) , implicating CD4 + T cells in this disease (Sawcer et al., 1996 (Sawcer et al., , 2005 Yeo et al., 2007) . This finding is consistent with the presence of CD4 + T cells among the CNS immune cell infiltrates observed in MS brain tissues (Booss et al., 1983; McCallum et al., 1987) , and is supported by the demonstration that CD4 + T cells are pathogenic in several animal models of autoimmune demyelination (reviewed, Delgado and Sheremata, 2006) . However, clinical studies have reported that anti-CD4 monoclonal antibody therapy in MS patients does not prevent disease (Lindsey et al., 1994; van Oosten et al., 1997 
